Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS).

Borruel S, Fernández-Durán E, Alpañés M, Martí D, Alvarez-Blasco F, Luque-Ramírez M, Escobar-Morreale HF.

J Clin Endocrinol Metab. 2013 Mar;98(3):1254-63. doi: 10.1210/jc.2012-3698.

PMID:
23386652
2.

Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS).

Martínez-García MÁ, Montes-Nieto R, Fernández-Durán E, Insenser M, Luque-Ramírez M, Escobar-Morreale HF.

J Clin Endocrinol Metab. 2013 Feb;98(2):E388-96. doi: 10.1210/jc.2012-3414.

PMID:
23337724
3.

Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index.

Borruel S, Moltó JF, Alpañés M, Fernández-Durán E, Álvarez-Blasco F, Luque-Ramírez M, Escobar-Morreale HF.

PLoS One. 2014 Dec 5;9(12):e114112. doi: 10.1371/journal.pone.0114112.

4.

Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome.

Barber TM, Golding SJ, Alvey C, Wass JA, Karpe F, Franks S, McCarthy MI.

J Clin Endocrinol Metab. 2008 Mar;93(3):999-1004.

PMID:
18089693
5.

PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity.

Huang ZH, Manickam B, Ryvkin V, Zhou XJ, Fantuzzi G, Mazzone T, Sam S.

J Clin Endocrinol Metab. 2013 Jan;98(1):E17-24. doi: 10.1210/jc.2012-2697.

6.

Sonographic measurement of mesenteric fat predicts presence of fatty liver among subjects with polycystic ovary syndrome.

Ma RC, Liu KH, Lam PM, Cheung LP, Tam WH, Ko GT, Chan MH, Ho CS, Lam CW, Chu WC, Tong PC, So WY, Chan JC, Chow CC.

J Clin Endocrinol Metab. 2011 Mar;96(3):799-807. doi: 10.1210/jc.2010-1608.

PMID:
21190980
7.

Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome.

Carmina E, Chu MC, Moran C, Tortoriello D, Vardhana P, Tena G, Preciado R, Lobo R.

Fertil Steril. 2008 Mar;89(3):642-8.

PMID:
17562334
8.

A nontargeted proteomic study of the influence of androgen excess on human visceral and subcutaneous adipose tissue proteomes.

Montes-Nieto R, Insenser M, Martínez-García MÁ, Escobar-Morreale HF.

J Clin Endocrinol Metab. 2013 Mar;98(3):E576-85. doi: 10.1210/jc.2012-3438.

PMID:
23348399
9.

Ultrasonographic extended-view technique for evaluation of abdominal fat distribution in lean women with polycystic ovary syndrome.

Battaglia C, Battaglia B, Mancini F, Paradisi R, Fabbri R, Venturoli S.

Acta Obstet Gynecol Scand. 2011 Jun;90(6):600-8. doi: 10.1111/j.1600-0412.2011.01124.x.

PMID:
21401530
10.

Body fat composition and distribution in women with polycystic ovary syndrome.

Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, Baş O.

Gynecol Endocrinol. 2008 Aug;24(8):428-32. doi: 10.1080/09513590802234253.

PMID:
18850379
11.

Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females.

Ezeh U, Pall M, Mathur R, Dey D, Berman D, Chen IY, Dumesic DA, Azziz R.

J Clin Endocrinol Metab. 2013 Apr;98(4):1541-8. doi: 10.1210/jc.2012-2937.

12.

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.

J Clin Endocrinol Metab. 2000 Aug;85(8):2767-74.

PMID:
10946879
13.

The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome.

Arpaci D, Gurkan Tocoglu A, Yilmaz S, Ergenc H, Tamer A, Keser N, Gunduz H.

J Ovarian Res. 2015 Nov 6;8:71. doi: 10.1186/s13048-015-0197-4.

14.
15.

Increased epicardial fat thickness is related with body mass index in women with polycystic ovary syndrome.

Soydinc E, Soydinc S, Arıturk Z, Tekbas E, Cakici M, Islamoglu Y, Ercan S, Sari I, Davutoglu V.

Eur Rev Med Pharmacol Sci. 2013;17(15):2111-3.

16.
17.

Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.

Mlinar B, Marc J, Jensterle M, Bokal EV, Jerin A, Pfeifer M.

J Steroid Biochem Mol Biol. 2011 Feb;123(3-5):127-32. doi: 10.1016/j.jsbmb.2010.12.002.

PMID:
21147223
18.

Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.

Ciccone MM, Favale S, Bhuva A, Scicchitano P, Caragnano V, Lavopa C, De Pergola G, Loverro G.

Vasc Health Risk Manag. 2009;5(3):561-6.

19.

Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.

Graff SK, Mário FM, Alves BC, Spritzer PM.

Fertil Steril. 2013 Oct;100(4):1081-8. doi: 10.1016/j.fertnstert.2013.06.005.

PMID:
23830153
20.

Correlates of increased lean muscle mass in women with polycystic ovary syndrome.

Carmina E, Guastella E, Longo RA, Rini GB, Lobo RA.

Eur J Endocrinol. 2009 Oct;161(4):583-9. doi: 10.1530/EJE-09-0398.

Items per page

Supplemental Content

Support Center